ABSTRACT
Vaccines are indispensable tools for public health, significantly reducing disease burden and mortality globally. However, their benefits are not equitably distributed, with African nations facing persistent challenges in accessing life-saving vaccines, a disparity starkly highlighted during the COVID-19 pandemic. This paper analyzes the multifaceted barriers hindering vaccine equity in Africa and proposes strategies for sustainable improvements. The primary challenges identified are economic, infrastructural, political, and socio-cultural. Economic constraints include high procurement costs, insufficient healthcare budgets, and the impact of intellectual property rights limiting local production. Infrastructural and logistical hurdles involve fragile cold chain systems, poor transportation networks, and human resource shortages, particularly in rural areas. Politically, vaccine nationalism by wealthier nations and regulatory inefficiencies in Low- and Middle-Income Countries (LMICs) exacerbate inequities. Furthermore, social and cultural factors such as vaccine hesitancy, fueled by misinformation and historical distrust, impede vaccine uptake. To address these complex issues, the paper advocates for a multi-pronged approach. Key recommendations include increased domestic investment in healthcare by African governments, strengthening supply chain management through modern energy solutions and digital technologies, and enhancing national regulatory capacities to ensure vaccine quality and safety. Promoting local vaccine production through supportive policies and international partnerships is crucial for self-sufficiency. Additionally, tackling socio-cultural barriers via community engagement and culturally sensitive public health campaigns, alongside a broader strengthening of primary healthcare systems, is essential. Ultimately, achieving vaccine equity in Africa requires a concerted effort to dismantle systemic barriers and foster regional collaboration. This will not only protect the health of African populations but also contribute to economic stability and the realization of fundamental human rights, ensuring the continent is better prepared for future health crises.
References
- Ekström AM, Tomson G, Wanyenze RK, Bhutta ZA, Kyobutungi C, Binagwaho A, Ottersen OP, Addressing production gaps for vaccines in African countries. Bulletin of the World Health Organization 99(12) (2021) 910–912. https://doi.org/10.2471/BLT.21.287381
- World Health Organization (WHO), Achieving 70% COVID-19 Immunization Coverage by Mid-2022. Retrieved Accessed on May 25, 2025.
- Van De Pas R, Widdowson MA, Ravinetto RN, Srinivas P, Ochoa TJ, Fofana TO, Van Damme W, COVID-19 vaccine equity: a health systems and policy perspective. Expert Review of Vaccines, 21(1) (2021) 25–36.
- Happi CT, Nkengasong JN, Two years of COVID‐19 in Africa: lessons for the world. Nature 601 (2022) 22–25
- Oluwole OR, Efunwoye OO, Adeeko A, Vaccination in livestock production: A veritable tool in the campaign for food security in Nigeria. A Review. Nigerian Journal of Animal Production (2019) 120–124.
- Food and Agriculture Organization (FAO). Improved Animal Health for Poverty Reduction and Sustainable Livelihoods. Retrieved from A4 .pdf Accessed on May 24, 2025.
- Center for Disease Control (CDC). About One Health. One Health, 2024. Retrieved from https://www.cdc.gov/one-health/about/index.html Accessed on May 24, 2025
- United Nations Development Program (UNDP). Global Dashboard for Vaccine Equity. UNDP Covid-19 Data Futures Platform, 2023. Retrieved
- Nkengasong JN, Ndembi N, Tshangela A, Raji T, COVID-19 vaccines: how to ensure Africa has access. Nature586(7828) (2020) 197- 199. https://doi.org/10.1038/d41586-020-02774-8
- Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, Basanez MG, et al, The global burden of disease study 2013: What does it mean for the NTDs? PloS Negl Trop Dis 11(8) (2017) e0005424. doi: 10.1371/journal.pntd.0005424
- Aborode AT, Olofinsao OA, Osmond E, Batubo AP, Fayemiro O, et al., Equal access of COVID‐19 vaccine distribution in Africa: Challenges and way forward. Journal of Medical Virology 93(9) (2021) 5212-5215. https://doi.org/10.1002/jmv.27095
- Lamptey E, Senkyire EK, Benita DA, Boakye EO. COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production. Clin Exp Vaccine Res. 11(1), (2022) 82-88. https://doi.org/10.7774/cevr.2022.11.1.82
- Makenga G, Bonoli S, Montomoli E, Carrier T, Auerbach J. Vaccine production in Africa: a feasible business model for capacity building and sustainable new vaccine introduction. Front Public Health 7 (2019) 56
- Saied AA, Metwally AA, Dhawan M, Choudhary OP, Aiash H. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. EMBO molecular medicine 14(8) (2022) e16287. https://doi.org/10.15252/emmm.202216287
- Ferranna M, Causes and costs of global COVID-19 vaccine inequity. Seminars in immunopathology45(4-6) (2024) 469–480. https://doi.org/10.1007/s00281-023-00998-0
- Figueroa JP, Hotez PJ, Batista C, Ben Amor Y, Ergonul O, Gilbert S, et al, Achieving global equity for COVID-19 vaccines: Stronger International Partnerships and Greater Advocacy and solidarity are needed. PLOS Medicine 18(9) (2021) https://doi.org/10.1371/journal.pmed.1003772
- Loewenson R. Structural Adjustment and Health Policy in Africa. International Journal of Health Services 23(4) (1993) 717–730. https://doi.org/10.2190/wbql-b4jp-k1pp-j7y3
- Lawal L, Aminu Bello M, Murwira T, Avoka C, Yusuf Ma’aruf S, Harrison Omonhinmin I, et al, Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Hum Vaccines Immunother 18(1) (2022) 2034457
Download all article in PDF
